Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002712518 | SCV003554357 | uncertain significance | Inborn genetic diseases | 2021-02-23 | criteria provided, single submitter | clinical testing | The c.3417G>C (p.K1139N) alteration is located in exon 20 (coding exon 20) of the CACNA1A gene. This alteration results from a G to C substitution at nucleotide position 3417, causing the lysine (K) at amino acid position 1139 to be replaced by an asparagine (N). The p.K1139N alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |